BridgeMD
New treatment option for URTI - Viral Upper Respiratory Tract Infection
Official title Evaluation Viral RNA and Virus Infectivity in Exhaled Air Before and After Use of One Dose With ColdZyme Mouth Spray
ClinicalTrials.gov ID: NCT07041671
What this study is testing
- What it's testing
- Many respiratory diseases spread through aerosols. ColdZyme is a mouth spray that protects against upper respiratory tract viruses causing common cold and flu-like symptoms.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- for subject selection:
- Male and female people above age 18 (inclusive).
- Presence of self-reported sudden onset of at least one of the following symptoms of upper respiratory tract infection case definitions for ILI and...
- Otherwise of general good health, according to Investigator's judgement.
- Willing and able to give written informed consent for participation in the investigation.
You likely can't join if
- for subject selection.
- Known allergy or hypersensitivity to the components of ColdZyme.
- Current use of immunosuppressive therapy within the last 4 weeks prior to Visit 1 and during the investigation.
- Diagnosed chronic respiratory disease that could potentially impact the investigation results, according to Investigator's judgement.
- Self-reported unhealed wounds/mucosal lesions in the mouth and/or throat.
- Participation in another clinical study or investigation within 30 days prior to Visit 1.
See the full eligibility criteria
- for subject selection:
- Male and female people above age 18 (inclusive).
- Presence of self-reported sudden onset of at least one of the following symptoms of upper respiratory tract infection case definitions for ILI and ARI (as defined by ECDC (EU 2008, 2012, 2022): Cough, sore throat...
- Otherwise of general good health, according to Investigator's judgement.
- Willing and able to give written informed consent for participation in the investigation.
- for subject selection.
- Known allergy or hypersensitivity to the components of ColdZyme.
- Current use of immunosuppressive therapy within the last 4 weeks prior to Visit 1 and during the investigation.
- Diagnosed chronic respiratory disease that could potentially impact the investigation results, according to Investigator's judgement.
- Self-reported unhealed wounds/mucosal lesions in the mouth and/or throat.
- Participation in another clinical study or investigation within 30 days prior to Visit 1.
- Active smokers
- The Investigator considers the subject unlikely to comply with investigational procedures, restrictions and requirements.
The study team makes the final eligibility decision.
Where it's taking place
- Lund, Sweden
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lund, Sweden. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.